Surmodics ( NASDAQ: SRDX ) awarded a group purchasing agreement for thrombectomy products with Premier, effective June 1, 2024. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Surmodics Pounce and Pounce Venous Thrombectomy Systems. Premier is a healthcare improvement company, uniting an alliance of more than 4,350 U.
S. hospitals. More on Surmodics Surmodics jumps 18% on acquisition by GTCR Surmodics beats top-line and bottom-line estimates; updates FY24 outlook Seeking Alpha’s Quant Rating on Surmodics Historical earnings data for Surmodics.